Andreas Muhlemann
Overview
Explore the profile of Andreas Muhlemann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malherbe P, Kratochwil N, Muhlemann A, Zenner M, Fischer C, Stahl M, et al.
J Neurochem
. 2006 Jun;
98(2):601-15.
PMID: 16805850
Fenobam [N-(3-chlorophenyl)-N'-(4,5-dihydro-1-methyl-4-oxo-1H-imidazole-2-yl)urea], a clinically validated non-benzodiazepine anxiolytic, has been shown to be a potent and non-competitive metabotropic glutamate (mGlu)-5 receptor antagonist. In the present study, we have used the site-directed...
2.
Muhlemann A, Ward N, Kratochwil N, Diener C, Fischer C, Stucki A, et al.
Eur J Pharmacol
. 2005 Dec;
529(1-3):95-104.
PMID: 16352303
Several mutations in the seven-transmembrane region of rat metabotropic glutamate 5 (rmGlu5) receptors were produced by site-directed mutagenesis and expressed in CHO cells. Using functional intracellular calcium ([Ca(2+)](i)) mobilisation, we...
3.
Kratochwil N, Malherbe P, Lindemann L, Ebeling M, Hoener M, Muhlemann A, et al.
J Chem Inf Model
. 2005 Sep;
45(5):1324-36.
PMID: 16180909
G protein-coupled receptors (GPCRs) share a common architecture consisting of seven transmembrane (TM) domains. Various lines of evidence suggest that this fold provides a generic binding pocket within the TM...
4.
Porter R, Jaeschke G, Spooren W, Ballard T, Buttelmann B, Kolczewski S, et al.
J Pharmacol Exp Ther
. 2005 Jul;
315(2):711-21.
PMID: 16040814
Fenobam [N-(3-chlorophenyl)-N'-(4,5-dihydro-1-methyl-4-oxo-1H-imidazole-2-yl)urea] is an atypical anxiolytic agent with unknown molecular target that has previously been demonstrated both in rodents and human to exert anxiolytic activity. Here, we report that fenobam...
5.
Muhlemann A, Diener C, Fischer C, Piussi J, Stucki A, Porter R
Br J Pharmacol
. 2005 Feb;
144(8):1118-25.
PMID: 15700023
1. Several combinations of cysteine to serine mutations at positions 57, 93, 99 and 129 in the extracellular N-terminal domain of human metabotropic 5a (hmGlu5a) receptors were produced and expressed...